Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3ζ, the signaling chain of the T-cell receptor complex

Blood

Volumn 91, Issue 2, 1998, Pages 585-594

  Trimble, Linda A ^a   Lieberman, Judy ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CENTER FOR BLOOD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GRANZYME A; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EFFECTOR CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTOTOXICITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS REPLICATION;

EID: 0031973577     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.2.585.585_585_594     Document Type: Article

References (53)

1. Hoffenbach A, Langlade-Demoyen P, Dadaglio G, Vilmer E, Michel F, Mayaud C, Autran B, Plata F: Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol 142:452, 1989
2. Moss PA, Rowland-Jones SL, Frodsham PM, McAdam S, Giangrande P, McMichael AJ, Bell JI: Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc Natl Acad Sci USA 92:5773, 1995
3. Altman JD, Moss PAH, Goulder PJR, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM: Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94, 1996
4. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and GD4 lymphocytes in HIV-1 infection. Nature 373:123, 1995
5. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifsoh JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM: Viral dynamics in human immunodeficiency type 1 infection. Nature 373:117, 1995
6. Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, Blumberg RS, Kaplan JC, Hirsch MS, Schooley RT: HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328:345, 1987
7. Koup RA, Sullivan JL, Levine PH, Brettler D, Mahr A, Mazzara G, McKenzie S, Panicali D: Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. Blood 73:1909, 1989
8. Riviere Y, Tanneau-Salvadori F, Regnault A, Lopez O, Sansonetti P, Guy B, Kieny MP, Fournel JJ, Montagnier L: Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: Distinct types of effector cells mediate killing of targets expressing gag and env proteins. J Virol 63:2270, 1989
9. Lieberman J, Fabry JA, Kuo MC, Earl P, Moss B, Skolnik PR: Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in Gp160 and reverse transcriptase. J Immunol 148:2738, 1992
10. Vanham G, Kestens L, Gigase P, Colebunders R, Vandenbruaene M, Brijs L, Ceuppens JL: Evidence for circulating activated cytotoxic T cells in HIV-infected subjects before the onset of opportunistic infections. Clin Exp Immunol 82:3, 1990
11. + cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol 150:3070, 1993
12. - cell population in the blood and lung of HIV-positive patients. J Acquir Immune Defic Syndr 6:1194, 1993
13. Mizoguchi HO, Shea JJ, Longo DL, Loeffler CM, McVicar DW, Ochoa AC: Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258:1795, 1992
14. Finke JH, Zea AH, Stanley J, Longo DL, Mizoguchi H, Tubbs RR, Wiltrout RH, O'Shea JJ, Kudoh S, Klein E, Bukowski RM, Ochea AC: Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res 53:5613, 1993
15. Massaia M, Attisano C, Beggiato E, Bianchi A, Piled A: Correlation between disease activity and T-cell CD3 zeta chain expression in a B-cell lymphoma. Br J Haematol 88:886, 1994
16. Renner C, Ohnesorge S, Held G, Bauer S, Jung W, Pfitzenmeier JP, Pfreundschuh M: T cells from patients with Hodgkin's disease have a detective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28. Blood 88:236, 1996
17. Weiss A, Littman DR: Signal transduction by lymphocyte antigen receptors. Cell 76:263, 1994
18. Exley M, Terhorst C, Wileman T: Structure, assembly and intracellular transport of the T cell receptor for antigen. Sem Immunol 3:283, 1991
19. Ono S, Ohno H, Saito T: Rapid turnover of the CD3 zeta chain independent of the TCR-CD3 complex normal T cells. Immunity 2:639, 1995
20. Centers for Disease Control: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 41:1, 1993
21. Beresford PJ, Kam C-M, Powers JC, Lieberman J: Recombinant human granzyme A binds to two putative HLA-associated proteins and cleaves one of them. Proc Natl Acad Sci USA 94:9285, 1997
22. Walker BD, Flexner C, Paradis TJ, Fuller TC, Hirsch MS, Schooley RT, Moss B: HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science 240:64, 1988
23. Pasternack MS, Eisen HN: A novel serine protease expressed by cytotoxic T lymphocytes. Nature 314:743, 1985
24. Podack ER, Young JD-E, Cohn ZA: Isolation and biochemical and functional characterization of perform 1 from cytolytic T cell granules. Proc Natl Acad Sci USA 82:8629, 1985
25. Jenne DE, Tschopp J: Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation. Immunol Rev 103:53, 1988
26. Gershenfeld HK, Weissman IL: Cloning of a cDNA for a T cell-specific serine protease from a cytotoxic T lymphocyte. Science 232:854, 1986
27. Stefanova I, Saville MW, Peters C, Cleghorn FR, Schwartz D, Venzon DJ, Weinhold KJ, Jack N, Bartolomew C, Blattner WA, Yarchoan R, Boten JB, Horak ID: HIV infection-Induced posttranslational modification of T cell signaling molecules associated with disease progression. J Clin Invest 98:1290, 1996
28. Shearer GM, Bernstein DC, Tung KS, Via CS, Redfield R, Salahuddin SZ, Gallo RC: A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J Immunol 137:2514, 1986
29. Baier-Bitterlich G, Baier G, Gulbins E, Coggeshall KM, Altman A: The role of p56lck in CD4-mediated suppression of CDS-induced early signaling events in T lymphocytes. Life Sci 56:1287, 1995
30. Jabado N, Pallier A, Le Deist F, Bernard F, Fischer A, Hivroz C: CD4 ligands inhibit the formation of multifunctional transduction complexes involved in T cell activation. J Immunol 158:94, 1997
31. Goldman F, Crabtree J, Hollenback C, Koretzky G: Sequestration of p56(lck) by gp 120, a model for TCR desensitization. J Immunol 158:2017, 1997
32. Briand G, Barbeau B, Tremblay M: Binding of HIV-1 to its receptor induces tyrosine phosphorylation of several CD4-associated proteins, including the phosphatidylinositol 3-kinase. Virology 228: 171,1997
33. Morio T, Chatila T, Geha RS: HIV glycoprotein gp120 inhibits TCR-CD3-mediated activation of fyn and lck. Int Immunol 9:53, 1997
34. Aiken C, Konner J, Landau NR, Lenburg ME, Trono D: Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76:853, 1994
35. Baur AS, Sawai ET, Dazin P, Fantl WJ, Cheng-Mayer C, Peterlin BM: HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1:373, 1994
36. + T cells inhibits the binding activity of NF-AT, NF-kappa B and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity. Eur J Immunol 24:2646, 1994
37. Collette Y, Dutartre H, Benziane A, Romas-Morales Benarous R, Harris M, Olive D: Physical and functional interaction of Nef with Lck. HIV-1 Net-induced T-cell signaling defects. J Biol Chem 271:6333, 1996
38. Iafrate AJ, Bronson S, Skowronski J: Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J 16:673, 1997
39. Yoo J, Chen H, Kraus T, Hirsch D, Polyak S, George I, Sperber K: Altered cytokine production and accessory cell function after HIV-1 infection. J Immunol 157:1313, 1996
40. Subramanyam M, Gutheil WG, Bachovchin WW, Huber BT: Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness. J Immunol 150:2544, 1993
41. Chirmule N, Than S, Khan SA, Pahwa S: Human immunodeficiency viras Tat induces functional unresponsiveness in T cells: J Virol 69:492, 1995
42. Gougeon ML, Laurent-Crawford AG, Hovanessian AG, Montagnier L: Direct and indirect mechanisms mediating apoptosis during HIV infection: Contribution to in vivo CD4 T cell depletion. Semin Immunol 5:187, 1993
43. + T cells from HIV-infected persons. J Immunol 153:412, 1994
44. + T cells. J Immunol 158:1551, 1997
45. Guarini A, Riera L, Cignetti A, Montacchini L, Massaia M, Foa R: Transfer of the interleukin-2 gene into human cancer cells induces specific antitumor recognition and restores the expression of CD3/T-cell receptor associated signal transduction molecules. Blood 89:212, 1997
46. Aoe T, Okamoto Y, Saito T: Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J Exp Med 181:1881, 1995
47. Otsuji M, Kimura Y, Aoe T, Okamoto Y, Saito T: Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses. Proc Natl Acad Sci USA 93:13119, 1996
48. Staal FJT, Ela SW, Roederer M, Anderson MA, Herzenberg LA: Glutathione deficiency and HIV infection. Lancet 339:909, 1992
49. + T lymphocytes in patients with acquired immunodeficiency syndrome (AIDS)-related complex or AIDS. Blood 81:2093, 1993
50. Riddell SR, Greenberg PD: Therapeutic reconstitution of human viral immunity by adoptive transfer of cytotoxic T lymphocyte clones. CurrTop Microbiol Immunol 189:9, 1994
51. Lieberman J, Skolnik PR, Parkerson GR, Fabry JA, Landry B, Bethel J, Kagan J, DATRI 006 Study Team: Safety of autologous, ex vivo-expanded HIV-specific cytotoxic T lymphocyte infusion in HIV-infected patients. Blood 90:2196, 1997
52. Kovacs JA, Baseler M, Dewar RJ, Vogel S, Davey RT Jr, Falloon J, Polis MA, Walker RE, Stevens R, Salzman NP, Metcalf JA, Masur H, Lane HC: Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. N Engl J Med 332:567, 1995
53. Jacobson EL, Pilaro F, Smith KA: Rational interleukin 2 therapy for HIV positive individuals: Daily low doses enhance immune function without toxicity. Proc Natl Acad Sci USA 93:10405, 1996